Related Experiment Video
Updated: Aug 28, 2025
08:36
Scaled-Up Preparation of an Intermediate of Upatinib, ACT051-3
Published on: April 7, 2023
1.2K
Roxadustat: Not just for anemia.
Xiaoyu Zhu1, Lili Jiang2, Xuejiao Wei1
1Department of Nephrology, The First Hospital of Jilin University, Changchun, Jilin, China.
Frontiers in Pharmacology
|September 15, 2022
Summary
Roxadustat effectively treats renal anemia by inhibiting hypoxia-inducible factor. While generally safe, vigilance is needed for potential off-target effects in other hypoxia-related conditions.
Area of Science:
- Pharmacology
- Anemia Treatment
- Hypoxia-Related Diseases
Background:
- Roxadustat is a novel hypoxia-inducible factor prolyl hydroxylase inhibitor.
- It has shown efficacy and safety in treating renal anemia.
- Emerging evidence suggests potential applications in other hypoxia-related conditions.
Purpose of the Study:
- To review the pharmacological profile of roxadustat.
- To discuss its current role in managing renal anemia.
- To explore potential off-target effects and other pathological mechanisms.
Main Methods:
- Literature review of pharmacological characteristics.
- Analysis of clinical trial data for renal anemia treatment.
- Exploration of HIF-independent effects and disease pathogenesis.
Main Results:
- Roxadustat demonstrates favorable safety and efficacy in renal anemia.
- Potential for treating other hypoxia-related diseases is under investigation.
- Some HIF-independent effects suggest possible off-target actions.
Conclusions:
- Roxadustat is a promising therapeutic agent for renal anemia.
- Further research is warranted to fully understand its safety profile and broader applications.
- Clinicians should remain aware of potential adverse or off-target effects.
Keywords:
angiogenesisfibrosishypoxia-inducible factorinflammationmetabolismoxidative stressrenal anemiaroxadustatMore Related Videos
Related Concept Videos
01:28Role of Hematopoietic Growth Factors
1.6K
Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Thrombopoietin (TPO), mainly released by the liver,...
1.6K
01:01Regulation of Hematopoietic Stem Cells
3.3K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.3K
01:27Disorders of Erythrocytes
1.2K
Disorders of erythrocytes, or red blood cells (RBCs), include a range of conditions affecting their number, shape, or function.
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
Erythrocyte disorders can be broadly categorized into two main types: anemic and polycythemic conditions.
A low oxygen-carrying capacity of the blood due to the loss, lower production, or destruction of erythrocytes is termed anemia. Hemorrhagic anemia, for example, occurs when bleeding from an external wound or internal ulcer reduces erythrocyte counts.
On the other...
1.2K
01:29Chemotherapy-Induced Nausea and Vomiting: Dopamine Receptor Antagonists
422
Dopamine receptor antagonists, also known as antipsychotic agents, are critical in managing chemotherapy-induced vomiting. These antiemetic agents block dopamine receptors in the chemoreceptor trigger zone (CTZ), inhibiting signal transmission to the vomiting center. Antipsychotic agents encompass phenothiazines (PTZ), butyrophenones, benzamides, and thienobenzodiazepines (Zyprexa), which are utilized for their antiemetic and sedative properties.
Phenothiazines, such as prochlorperazine...
Phenothiazines, such as prochlorperazine...
422
01:14Erythropoiesis
4.6K
Red blood cells (RBCs) transport oxygen to all body tissues. These cells survive only for 120 days and then need to be replenished. Erythropoiesis is the process of RBC production. In healthy individuals, erythropoiesis ensures all tissues are amply supplied with oxygen. In addition, blood loss due to injury leads to a drop in the physiological oxygen level that will cause erythropoiesis. Any defect in erythropoiesis leads to several physiological disorders, including thalassemia, anemia,...
4.6K
01:21Hematopoiesis
5.5K
The process of blood cell formation is called hematopoiesis. Hematopoiesis starts early during development, on the seventh day of embryogenesis. This phase of hematopoiesis is called the primitive wave, wherein the extraembryonic yolk sac allows the production of erythroid cells and endothelial cells from a common precursor called hemangioblast. The erythroid cells provide oxygen to support the growth of the rapidly dividing embryo. Hemangioblasts later develop into hematopoietic stem cells or...
5.5K